Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island
Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island
Organogenesis宣布计划通过长期租赁方式，在罗德岛史密斯菲尔德市的100 Technology Way处扩大制造能力的生物制造设施。
Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way in Smithfield, Rhode Island.
Organogenesis控股公司（纳斯达克：ORGO），一家领先的再生医学公司，专注于开发、制造和商业化在Advanced Wound Care和手术及体育医学市场产品解决方案，宣布计划通过租赁长期租约，扩大在罗德岛史密斯菲尔德市100 Technology Way的122,000平方英尺最先进的生物制造设施的制造能力。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间